jaeaffiliates.blogg.se

M spike serum 2
M spike serum 2




m spike serum 2

  • ^ a b Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al.
  • "Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group".
  • ^ a b International Myeloma Working Group (June 2003).
  • "Pathophysiology of paraprotein production".
  • ^ "Multiple Myeloma Patient Handbook".
  • Über die Störungen des Eiweißstoffwechsels bei Plasmozytomen".
  • Monoclonal gammopathy of undetermined significance.
  • Detection of paraprotein in serum of less than 30 g/l is classified as monoclonal gammopathy of undetermined significance in cases where clonal plasma cells constitute less than 10% on bone marrow biopsy and there is no myeloma-related organ or tissue impairment. Elevated paraprotein level (above 30 g/l) in conjunction with end organ damage (elevated calcium, kidney failure, anemia, or bone lesions) or other biomarkers of malignancy, is diagnostic of multiple myeloma, according to the diagnostic criteria of the International Myeloma Working Group, which were updated in 2014.

    #M spike serum 2 free#

    Monoclonal free light chains in the serum or urine are called Bence Jones proteins.īlood serum paraprotein levels of more than 30 g/l is diagnostic of smouldering myeloma, an intermediate in a spectrum of step-wise progressive diseases termed plasma cell dyscrasias. Serum free light-chain measurement can detect free light chains in the blood. Unlike normal immunoglobulin antibodies, paraproteins cannot fight infection. Paraproteins form a narrow band, or 'spike' in protein electrophoresis as they are all exactly the same protein. An excess in the blood is known as paraproteinemia. and Concise Review ĭetection of paraproteins in the urine or blood is most often associated with benign monoclonal gammopathy of undetermined significance (MGUS), where they remain "silent", and multiple myeloma. An explanation of the difference between multiple myeloma and MGUS can be found in the International Myeloma Foundation's Patient Handbook.

    m spike serum 2

    People will sometimes develop a condition called MGUS ( Monoclonal gammopathy of undetermined significance), where there is overproduction of one antibody but the condition is benign (non-cancerous). When there is a malignant clone, there is usually overproduction of a single antibody, resulting in a "spike" on the normal distribution (sharp peak on the graph), which is called an M spike (or monoclonal spike). As a result, there is a characteristic normal distribution of these antibodies in the blood by molecular weight. Each type of antibody has a different number of light chain and heavy chain pairs. When someone has myeloma, a malignant clone, a rogue plasma cell, reproduces in an uncontrolled fashion, resulting in overproduction of the specific antibody the original cell was generated to produce. Antibodies are typically grouped into five types: IgA, IgD, IgE, IgG, and IgM. There are thousands of different antibodies, each consisting of pairs of heavy and light chains. Plasma cells produce immunoglobulins, which are commonly called antibodies. Paraproteins allowed the detailed study of immunoglobulins, which eventually led to the production of monoclonal antibodies in 1975. The concept and the term paraprotein were introduced by the Berlin pathologist Dr Kurt Apitz in 1940, then the senior physician of the pathological institute at the Charité hospital.






    M spike serum 2